Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FQWVN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,385
Award facts
- Contract value 100% obligated
- $15,385.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,385.14 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, and falls within the Defense Logistics Agency's medical supply procurement portfolio supporting military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen serves as a critical prime vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's extensive federal contract portfolio demonstrates its established capability to meet stringent federal procurement requirements for specialized pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FQWVN?
SPE2DB26FQWVN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FQWVN worth?
The government has obligated $15,385 on SPE2DB26FQWVN.
Is contract SPE2DB26FQWVN an order under another contract?
Yes. SPE2DB26FQWVN is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB26FQWVN competed?
The extent of competition for SPE2DB26FQWVN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award